Density of Langerhans Cells in Nonmelanoma Skin Cancers: A Systematic Review
Langerhans cells (LCs) are bone marrow-derived dendritic cells (DCs) that represent 2-3% of the entire cell population of the human skin, known to have an ability to present antigens to T lymphocytes. Moreover, there is evidence that LCs are probably capable of inducing the local cytotoxic type T-ce...
Saved in:
Main Authors: | Joanna Pogorzelska-Dyrbuś, Jacek C. Szepietowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2020/8745863 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
by: K. C. Masoumi, et al.
Published: (2011-01-01) -
Teledermatology: From Prevention to Diagnosis of Nonmelanoma and Melanoma Skin Cancer
by: G. Fabbrocini, et al.
Published: (2011-01-01) -
Diet and Skin Cancer: The Potential Role of Dietary Antioxidants in Nonmelanoma Skin Cancer Prevention
by: Rajani Katta, et al.
Published: (2015-01-01) -
Sentinel Lymph Node Biopsy in Nonmelanoma Skin Cancer Patients
by: Marie-Laure Matthey-Giè, et al.
Published: (2013-01-01) -
Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer
by: Mehdi Ghahartars, et al.
Published: (2021-01-01)